Table 3.
Dosages of strong opioids received immediately prior to treatment with tapentadol PR.
| Aged >65 years | Aged ≤65 years | |
|---|---|---|
| Fentanyl (transdermal) | 129 | 36 |
| ≤25 μg/h | 53 | 17 |
| 50 μg/h | 36 | 7 |
| ≥75 μg/h | 40 | 12 |
| Oxycodone/naloxone | 74a | 30 |
| ≤40 mg/day | 66 | 23 |
| 41–80 mg/day | 7 | 6 |
| >80 mg/day | 0 | 1 |
| Oxycodone | 61a | 26 |
| ≤40 mg/day | 49 | 18 |
| 41–80 mg/day | 8 | 7 |
| >80 mg/day | 3 | 1 |
| Buprenorphine | 56a | 9 |
| ≤20 μg/h | 33 | 9 |
| 35 μg/h | 12 | 0 |
| 52.5 μg/h | 6 | 0 |
| 70 μg/h | 4 | 0 |
| Morphine | 37 | 19a |
| ≤60 mg/day | 26 | 10 |
| 61–120 mg/day | 8 | 7 |
| >120 mg/day | 3 | 1 |
| Hydromorphone | 33 | 9a |
| ≤8 mg/day | 8 | 4 |
| 9–16 mg/day | 17 | 2 |
| >16 mg/day | 8 | 2 |
Data are number of patients. aData missing for one patient. PR, prolonged release.